Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Multicenter, Double-Blind Study of the Safety, Tolerability, and Immunogenicity of a Pneumococcal Conjugate Vaccine (V114) Compared to Pneumococcal Polysaccharide Vaccine (PNEUMOVAX ? 23) and Prevnar 13? (Pneumococcal 13-Valent Conjugate Vaccine [Diphtheria CRM197 Protein]) in Healthy Adults 50 Years of Age or Older Estudio multicéntrico y doble ciego de la seguridad, tolerabilidad e inmunogenicidad de una vacuna antineumocócica conjugada (V114) en comparación con una vacuna antineumocócica de polisacáridos (PNEUMOVAX?23) y Prevenar 13? (vacuna antineumocócica conjugada 13 valente [proteína diftérica CRM197]) en adultos sanos de 50 años o más de edad https://kusajili.com:443/Trial/aXW_cf5NPUWHN-MhSzHVRg%24a-multicenter-double-blind-study-of-the-safety-tolerability-and-immunogenicity-of-a-pneumococcal-conjugate-vaccine-v114-compare
I have read and accept the terms of use of the site and the Privacy Policy
Send your message